OPKO Health Share Holder Equity 2010-2024 | OPK

OPKO Health share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
OPKO Health Annual Share Holder Equity
(Millions of US $)
2024 $1,365
2023 $1,389
2022 $1,562
2021 $1,685
2020 $1,672
2019 $1,615
2018 $1,791
2017 $1,844
2016 $2,092
2015 $1,980
2014 $836
2013 $873
2012 $179
2011 $161
2010 $23
2009 $32
OPKO Health Quarterly Share Holder Equity
(Millions of US $)
2024-12-31 $1,365
2024-09-30 $1,403
2024-06-30 $1,395
2024-03-31 $1,253
2023-12-31 $1,389
2023-09-30 $1,445
2023-06-30 $1,535
2023-03-31 $1,552
2022-12-31 $1,562
2022-09-30 $1,629
2022-06-30 $1,719
2022-03-31 $1,615
2021-12-31 $1,685
2021-09-30 $1,766
2021-06-30 $1,743
2021-03-31 $1,697
2020-12-31 $1,672
2020-09-30 $1,624
2020-06-30 $1,588
2020-03-31 $1,549
2019-12-31 $1,615
2019-09-30 $1,642
2019-06-30 $1,709
2019-03-31 $1,763
2018-12-31 $1,791
2018-09-30 $1,789
2018-06-30 $1,810
2018-03-31 $1,823
2017-12-31 $1,844
2017-09-30 $2,089
2017-06-30 $2,107
2017-03-31 $2,107
2016-12-31 $2,092
2016-09-30 $2,105
2016-06-30 $2,016
2016-03-31 $1,998
2015-12-31 $1,980
2015-09-30 $1,969
2015-06-30 $827
2015-03-31 $813
2014-12-31 $836
2014-09-30 $887
2014-06-30 $913
2014-03-31 $831
2013-12-31 $873
2013-09-30 $868
2013-06-30 $312
2013-03-31 $320
2012-12-31 $179
2012-09-30 $146
2012-06-30 $152
2012-03-31 $155
2011-12-31 $161
2011-09-30 $102
2011-06-30 $111
2011-03-31 $124
2010-12-31 $23
2010-09-30 $20
2010-06-30 $50
2010-03-31 $56
2009-12-31 $32
2009-09-30 $64
2009-06-30 $39
2009-03-31 $-8
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.115B $0.713B
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $187.725B 22.76
Intuitive Surgical (ISRG) United States $176.405B 80.93
Alcon (ALC) Switzerland $46.824B 31.12
Edwards Lifesciences (EW) United States $42.608B 27.66
IDEXX Laboratories (IDXX) United States $34.032B 39.36
IQVIA Holdings (IQV) United States $31.084B 17.20
DexCom (DXCM) United States $26.777B 41.39
Mettler-Toledo (MTD) United States $24.611B 28.69
STERIS (STE) Ireland $22.269B 25.47
Waters (WAT) United States $21.897B 31.05
SONOVA HOLDING (SONVY) Switzerland $17.380B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $14.612B 14.91
Hologic (HOLX) United States $13.861B 14.96
Sysmex ADR (SSMXY) Japan $11.941B 37.44
Penumbra (PEN) United States $10.300B 93.17
Globus Medical (GMED) United States $10.068B 23.31
Masimo (MASI) United States $9.002B 37.78
Teleflex (TFX) United States $6.407B 9.86
Glaukos (GKOS) United States $5.567B 0.00
Integer Holdings (ITGR) United States $3.967B 22.27
PROCEPT BioRobotics (PRCT) United States $3.194B 0.00
Veracyte (VCYT) United States $2.311B 41.76
TransMedics (TMDX) United States $2.265B 66.61
Nihon Kohden (NHNKY) Japan $2.205B 12.06
LivaNova (LIVN) United Kingdom $2.135B 12.96
Elekta AB (EKTAY) Sweden $1.995B 17.93
Integra LifeSciences Holdings (IART) United States $1.698B 8.59
Alphatec Holdings (ATEC) United States $1.462B 0.00
Tandem Diabetes Care (TNDM) United States $1.274B 0.00
Paragon 28 (FNA) United States $1.096B 0.00
Artivion (AORT) United States $1.034B 98.32
RxSight (RXST) United States $1.022B 0.00
Pulse Biosciences (PLSE) United States $0.990B 0.00
AxoGen (AXGN) United States $0.820B 0.00
IRadimed (IRMD) United States $0.667B 34.99
AVANOS MEDICAL, INC (AVNS) United States $0.659B 10.61
Mesa Laboratories (MLAB) United States $0.645B 14.09
ORTHOFIX MEDICAL INC (OFIX) United States $0.636B 0.00
OrthoPediatrics (KIDS) United States $0.598B 0.00
SiBone (SIBN) United States $0.596B 0.00
Beta Bionics (BBNX) United States $0.531B 0.00
Treace Medical Concepts (TMCI) United States $0.525B 0.00
Delcath Systems (DCTH) United States $0.425B 0.00
NeuroPace (NPCE) United States $0.400B 0.00
AngioDynamics (ANGO) United States $0.380B 0.00
Pacific Biosciences Of California (PACB) United States $0.351B 0.00
Semler Scientific (SMLR) United States $0.347B 7.37
ClearPoint Neuro (CLPT) United States $0.329B 0.00
CVRx (CVRX) United States $0.318B 0.00
Tactile Systems Technology (TCMD) United States $0.313B 16.73
Nevro (NVRO) United States $0.224B 0.00
Inogen (INGN) United States $0.192B 0.00
Accuray (ARAY) United States $0.184B 0.00
Alpha Tau Medical (DRTS) Israel $0.177B 0.00
LENSAR (LNSR) United States $0.166B 0.00
908 Devices (MASS) United States $0.158B 0.00
Spectral Diagnostics (EDTXF) Canada $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.135B 0.00
Anteris Technologies Global (AVR) Australia $0.131B 0.00
Sight Sciences (SGHT) United States $0.123B 0.00
KORU Medical Systems (KRMD) United States $0.117B 0.00
Rapid Micro Biosystems (RPID) United States $0.114B 0.00
Neuronetics (STIM) United States $0.112B 0.00
Monogram Orthopaedics (MGRM) United States $0.104B 0.00
Atossa Genetics (ATOS) United States $0.087B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.078B 11.82
EDAP TMS S.A (EDAP) France $0.073B 0.00
Zomedica (ZOMDF) United States $0.057B 0.00
Hyperfine (HYPR) United States $0.056B 0.00
Microbot Medical (MBOT) United States $0.052B 0.00
EnVVeno Medical (NVNO) United States $0.046B 0.00
Vicarious Surgical (RBOT) United States $0.039B 0.00
Baird Medical Investment Holdings (BDMD) $0.034B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.027B 0.00
Envoy Medical (COCH) United States $0.026B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
NexGel (NXGL) United States $0.023B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
Adagio Medical Holdings (ADGM) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Aspira Women's Health (AWH) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00